Key facts
- Notable investors include HSG (Hong Kong), Addor Capital, Innoval Capital, Infinity Group, Yongxin Capital — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for MeiDongHuiCheng
- ·The full record, as it builds
Funding rounds
No funding rounds for MeiDongHuiCheng are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MeiDongHuiCheng
Provider of laboratory automation equipment designed to build a comprehensive manufacturing and service platform. The company provides biological consumables in the field of minimally invasive surgery and life sciences including automated robotics, automatic pipette tip, PCR series, nucleic acid extraction and sampling, purification reagent, etc. based on high-precision molds, electric injection molding machines and PP materials, providing customers with high-quality biological consumables.
- Sector
- Healthcare
- HQ
- Kunshan, China
- Founded
- 2021
- Employees
- 800
- Website
- mdhc-bio.com/
- Ownership
- Privately Held (backing)
MeiDongHuiCheng doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MeiDongHuiCheng shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MeiDongHuiCheng in its N-PORT filings yet. We sweep new filings monthly.